Total Payments
$5,529
2022 Payments
$13.93
Companies
41
Transactions
475
Medicare Patients
9,909
Medicare Billing
$366,143
Payment Breakdown by Category
Food & Beverage$5,503 (99.5%)
Education$26.82 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,503 | 472 | 99.5% |
| Education | $26.82 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $617.49 | 89 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $507.38 | 34 | $0 (2021) |
| Amarin Pharma Inc. | $432.76 | 32 | $0 (2021) |
| GlaxoSmithKline, LLC. | $418.50 | 38 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $410.07 | 30 | $0 (2021) |
| Allergan, Inc. | $294.58 | 20 | $0 (2020) |
| Amgen Inc. | $256.35 | 17 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $230.09 | 29 | $0 (2021) |
| Novo Nordisk Inc | $229.10 | 17 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $217.10 | 22 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.93 | 1 | ABBVIE INC. ($13.93) |
| 2021 | $762.86 | 56 | AbbVie Inc. ($177.73) |
| 2020 | $964.02 | 65 | Allergan, Inc. ($193.45) |
| 2019 | $916.27 | 82 | PFIZER INC. ($196.11) |
| 2018 | $1,488 | 138 | PFIZER INC. ($232.10) |
| 2017 | $1,384 | 133 | GlaxoSmithKline, LLC. ($159.82) |
All Payment Transactions
475 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2021 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: VACCINES | ||||||
| 09/17/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Diabetes | ||||||
| 09/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Cardiovascular | ||||||
| 09/02/2021 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological), Fluad Quadrivalent | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: Vaccines | ||||||
| 09/02/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Cardiovascular | ||||||
| 08/09/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: CNS | ||||||
| 08/02/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: DIABETES | ||||||
| 08/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.25 | General |
| Category: PSYCHOLOGY | ||||||
| 07/21/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
| 07/19/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular | ||||||
| 07/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PRIMARY CARE | ||||||
| 07/12/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: CNS | ||||||
| 07/08/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: DIABETES | ||||||
| 07/07/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.51 | General |
| Category: PSYCHOLOGY | ||||||
| 06/29/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2021 | Adlon Therapeutics L.P. | ADHANSIA XR (Drug) | Food and Beverage | Cash or cash equivalent | $21.46 | General |
| Category: PRESCRIPTION STIMULANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 418 | 546 | $49,749 | $20,829 |
| 2021 | 50 | 5,033 | 7,119 | $455,326 | $193,901 |
| 2020 | 47 | 4,458 | 6,731 | $410,311 | $151,412 |
Total Patients
9,909
Total Services
14,396
Medicare Billing
$366,143
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 201 | $26,784 | $11,656 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 110 | $20,807 | $8,159 | 39.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 128 | 194 | $971.14 | $561.51 | 57.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 13 | $1,075 | $392.27 | 36.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 28 | 28 | $112.00 | $60.49 | 54.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 382 | 702 | $90,120 | $40,406 | 44.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 255 | 383 | $71,060 | $30,976 | 43.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 165 | 165 | $24,793 | $21,485 | 86.7% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 178 | 178 | $17,800 | $14,465 | 81.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 132 | 411 | $51,400 | $10,037 | 19.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 338 | 443 | $13,070 | $7,442 | 56.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 338 | 456 | $11,946 | $6,095 | 51.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 102 | 123 | $8,594 | $5,563 | 64.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 354 | 495 | $29,137 | $5,227 | 17.9% |
| 82306 | Vitamin d-3 level | Office | 2021 | 157 | 178 | $12,600 | $5,185 | 41.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 337 | 442 | $8,625 | $4,277 | 49.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 25 | 25 | $4,375 | $4,134 | 94.5% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2021 | 185 | 233 | $7,493 | $3,947 | 52.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 354 | 501 | $14,752 | $3,893 | 26.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 56 | 73 | $8,215 | $2,479 | 30.2% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 55 | 122 | $3,840 | $2,019 | 52.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 30 | 31 | $2,579 | $1,945 | 75.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 99 | 99 | $3,465 | $1,815 | 52.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 382 | 604 | $4,515 | $1,807 | 40.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 154 | 192 | $3,702 | $1,732 | 46.8% |
About Dr. Robert Miller, MD
Dr. Robert Miller, MD is a Family Medicine healthcare provider based in Weatherford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801892443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Miller, MD has received a total of $5,529 in payments from pharmaceutical and medical device companies, with $13.93 received in 2022. These payments were reported across 475 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($5,503).
As a Medicare-enrolled provider, Miller has provided services to 9,909 Medicare beneficiaries, totaling 14,396 services with total Medicare billing of $366,143. Data is available for 3 years (2020–2022), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Weatherford, TX
- Active Since 06/27/2005
- Last Updated 01/15/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801892443
Products in Payments
- ELIQUIS (Drug) $447.06
- Vascepa (Drug) $432.76
- TROKENDI XR (Drug) $338.74
- UBRELVY (Drug) $263.84
- SYMBICORT (Drug) $181.82
- FARXIGA (Drug) $179.82
- VRAYLAR (Drug) $166.62
- ANORO (Drug) $154.69
- Prolia (Biological) $149.09
- XARELTO (Drug) $140.37
- SHINGRIX (Biological) $120.83
- MYDAYIS (Drug) $105.63
- BELSOMRA (Drug) $97.45
- MYRBETRIQ (Drug) $95.79
- BEVESPI AEROSPHERE (Drug) $93.82
- APTIOM (Drug) $89.68
- JARDIANCE (Drug) $89.33
- Tresiba (Drug) $88.65
- LATUDA (Drug) $87.44
- VYVANSE (Drug) $84.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Weatherford
Adam Khadbai, M.d, M.D
Family Medicine — Payments: $18,816
Family Medicine $18,816
Rupa Pachigolla, M.d, M.D
Family Medicine — Payments: $9,183
Family Medicine $9,183
Steven Melcher, M.d, M.D
Family Medicine — Payments: $5,814
Family Medicine $5,814
Dr. Blake Badgett, M.d, M.D
Family Medicine — Payments: $4,884
Family Medicine $4,884
Miguel Gutierrez, Md, MD
Family Medicine — Payments: $4,767
Family Medicine $4,767
Andrea Ford, Do, DO
Family Medicine — Payments: $2,543
Family Medicine $2,543